{"id":"https://openalex.org/W2073070157","doi":"https://doi.org/10.1210/jcem.86.7.7564","title":"Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?","display_name":"Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?","alternate_titles":[],"publication_year":2001,"publication_date":"2001-07-01","ids":{"openalex":"https://openalex.org/W2073070157","doi":"https://doi.org/10.1210/jcem.86.7.7564","mag":"2073070157","pmid":"https://pubmed.ncbi.nlm.nih.gov/11443197"},"language":"en","primary_location":{"id":"doi:10.1210/jcem.86.7.7564","doi":"https://doi.org/10.1210/jcem.86.7.7564","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.86.7.7564","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073070157"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032881983","display_name":"Ahmad Aljada","orcid":"https://orcid.org/0000-0001-8337-5454","observed_orcids":["https://orcid.org/0000-0001-8337-5454"]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Aljada","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209, USA","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014116477","display_name":"Rajesh Garg","orcid":"https://orcid.org/0000-0002-7779-1619","observed_orcids":["https://orcid.org/0000-0002-7779-1619"]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajesh Garg","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079289558","display_name":"Husam Ghanim","orcid":"https://orcid.org/0000-0002-6333-6033","observed_orcids":["https://orcid.org/0000-0002-6333-6033","https://orcid.org/0000-0003-3747-1298"]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Husam Ghanim","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110005088","display_name":"Priya Mohanty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priya Mohanty","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078646052","display_name":"Wael Hamouda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wael Hamouda","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046946444","display_name":"Ezzat Assian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezzat Assian","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032877471","display_name":"Paresh Dandona","orcid":"https://orcid.org/0000-0002-7055-2084","observed_orcids":["https://orcid.org/0000-0002-7055-2084"]},"institutions":[{"id":"https://openalex.org/I1325611130","display_name":"Kaleida Health","ror":"https://ror.org/02sb3pg33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325611130"]},{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paresh Dandona","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, State University of New York, and Kaleida Health, Buffalo, New York 14209","institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032877471"],"corresponding_institution_ids":["https://openalex.org/I1325611130","https://openalex.org/I1327163397"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":8.5486,"has_fulltext":true,"cited_by_count":168,"citation_normalized_percentile":{"value":0.9844229,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"86","issue":"7","first_page":"3250","last_page":"3256"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.7548999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.7548999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.133200004696846,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.03849999979138374,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":1.0},{"id":"https://openalex.org/keywords/nuclear-factor-kappab","display_name":"nuclear factor-kappaB","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ikappab","display_name":"I\u03baB","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8730000257492065},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mononuclear-cells","display_name":"mononuclear cells","score":0.8849999904632568},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9110000133514404},{"id":"https://openalex.org/keywords/p47phox","display_name":"p47phox","score":0.9079999923706055},{"id":"https://openalex.org/keywords/9-hydroxyoctadecadienoic-acid","display_name":"9-hydroxyoctadecadienoic acid","score":0.9139999747276306},{"id":"https://openalex.org/keywords/13-hode","display_name":"13-hydroxyoctadecadienoic acid","score":0.9359999895095825},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7250000238418579},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9760000109672546},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.9668895602226257},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6408119201660156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6058780550956726},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.546930730342865},{"id":"https://openalex.org/C2776165026","wikidata":"https://www.wikidata.org/wiki/Q188017","display_name":"Tyrosine","level":2,"score":0.4241277873516083},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3450987935066223},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33151674270629883},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23414424061775208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21933132410049438},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.1988542377948761},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09346890449523926}],"mesh":[{"descriptor_ui":"D000077288","descriptor_name":"Troglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002839","descriptor_name":"Chromans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002839","descriptor_name":"Chromans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008041","descriptor_name":"Linoleic Acids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010750","descriptor_name":"Phosphoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014443","descriptor_name":"Tyrosine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017395","descriptor_name":"Plasminogen Activator Inhibitor 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018932","descriptor_name":"Chemokine CCL2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019255","descriptor_name":"NADPH Oxidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019787","descriptor_name":"Linoleic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020672","descriptor_name":"I-kappa B Proteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D044243","descriptor_name":"Linoleic Acids, Conjugated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1210/jcem.86.7.7564","doi":"https://doi.org/10.1210/jcem.86.7.7564","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.86.7.7564","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"doi:10.1210/jc.86.7.3250","doi":"https://doi.org/10.1210/jc.86.7.3250","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.86.7.3250","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:11443197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11443197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W88936571","https://openalex.org/W131863817","https://openalex.org/W1520101097","https://openalex.org/W1633340712","https://openalex.org/W1639924204","https://openalex.org/W1792804645","https://openalex.org/W1803681061","https://openalex.org/W1973270637","https://openalex.org/W1973289509","https://openalex.org/W1975375148","https://openalex.org/W1984255117","https://openalex.org/W1987172787","https://openalex.org/W1987513395","https://openalex.org/W2001754734","https://openalex.org/W2003115027","https://openalex.org/W2013637636","https://openalex.org/W2019662294","https://openalex.org/W2029186389","https://openalex.org/W2045065016","https://openalex.org/W2047591801","https://openalex.org/W2053371559","https://openalex.org/W2057784785","https://openalex.org/W2066528695","https://openalex.org/W2068077370","https://openalex.org/W2092881968","https://openalex.org/W2094646101","https://openalex.org/W2120549911","https://openalex.org/W2123663011","https://openalex.org/W2131632143","https://openalex.org/W2136785104","https://openalex.org/W2138809584","https://openalex.org/W2142031401","https://openalex.org/W2150968126","https://openalex.org/W2169280145","https://openalex.org/W2173762551","https://openalex.org/W2263089270","https://openalex.org/W2288900222","https://openalex.org/W2316376271","https://openalex.org/W2319385954","https://openalex.org/W2324841714","https://openalex.org/W2331176038","https://openalex.org/W2411167902","https://openalex.org/W2791871807","https://openalex.org/W3190844582","https://openalex.org/W4237516951","https://openalex.org/W4255635293"],"related_works":["https://openalex.org/W2142031401","https://openalex.org/W2027695069","https://openalex.org/W2049501468","https://openalex.org/W2014113220","https://openalex.org/W2109417190","https://openalex.org/W7098518723","https://openalex.org/W2048937063","https://openalex.org/W1997485867","https://openalex.org/W1519269750","https://openalex.org/W2150968126"],"abstract_inverted_index":{"It":[0],"has":[1,234],"been":[2],"shown":[3],"recently":[4,255],"that":[5,232],"troglitazone":[6,28,66,99,124,148,175,207,218,233,261],"exerts":[7],"an":[8],"anti-inflammatory":[9],"effect,":[10],"in":[11,14,21,41,82,116,238,243],"vitro,":[12],"and":[13,36,45,57,80,129,153,164,191,200,211,222],"experimental":[15],"animals.":[16],"To":[17],"test":[18],"these":[19,248],"properties":[20],"humans,":[22],"we":[23],"investigated":[24],"the":[25,30,63,139,158,254,263],"effect":[26,64],"of":[27,65,260],"on":[29,67],"proinflammatory":[31],"transcription":[32],"factor":[33],"nuclear":[34,118],"factor-kappaB":[35,113],"its":[37],"inhibitory":[38],"protein":[39,143,195,202],"IkappaB":[40,142],"mononuclear":[42],"cells":[43,190],"(MNC)":[44],"plasma":[46],"soluble":[47,165],"intracellular":[48,166],"adhesion":[49,167],"molecule-1,":[50],"monocyte":[51,161],"chemoattractant":[52,162],"protein-1,":[53],"plasminogen":[54,197],"activator":[55,198],"inhibitor-1,":[56,199],"C-reactive":[58,201],"protein.":[59],"We":[60],"also":[61,215],"examined":[62],"reactive":[68],"oxygen":[69,185],"species":[70,186],"generation,":[71],"p47(phox)":[72,193],"subunit":[73,194],"expression,":[74],"9-hydroxyoctadecadienoic":[75],"acid":[76,210,213],"(9-HODE),":[77],"13-HODE,":[78],"o-tyrosine,":[79],"m-tyrosine":[81],"obese":[83,90,244],"patients":[84,91],"with":[85,92,98],"type":[86,93,245],"2":[87,94,246],"diabetes.":[88],"Seven":[89],"diabetes":[95],"were":[96,107],"treated":[97],"(400":[100],"mg/day)":[101],"for":[102],"4":[103],"weeks.":[104],"Blood":[105],"samples":[106],"obtained":[108],"at":[109,126,150,262],"weekly":[110],"intervals.":[111],"Nuclear":[112],"binding":[114],"activity":[115],"MNC":[117],"extracts":[119],"was":[120,179],"significantly":[121,146,173,205],"inhibited":[122,133],"after":[123,147,174,206,217],"treatment":[125,149],"week":[127,136,151],"1":[128],"continued":[130],"to":[131,135,240,253],"be":[132,251],"up":[134],"4.":[137],"On":[138],"other":[140],"hand,":[141],"levels":[144,203],"increased":[145],"1,":[152],"this":[154],"increase":[155],"persisted":[156],"throughout":[157],"study.":[159],"Plasma":[160],"protein-1":[163],"molecule-1":[168],"concentrations":[169],"did":[170,225],"not":[171,226],"decrease":[172],"treatment,":[176],"although":[177],"there":[178],"a":[180],"trend":[181],"toward":[182],"inhibition.":[183],"Reactive":[184],"generation":[187],"by":[188],"polymorphonuclear":[189],"MNC,":[192],"quantities,":[196],"decreased":[204,216],"intake.":[208,219],"13-HODE/linoleic":[209],"9-HODE/linoleic":[212],"ratios":[214,224],"However,":[220],"o-tyrosine/phenylalanine":[221],"m-tyrosine/phenylalanine":[223],"change":[227],"significantly.":[228],"These":[229],"data":[230],"show":[231],"profound":[235],"antiinflammatory":[236],"effects":[237,242,249,259],"addition":[239],"antioxidant":[241],"diabetics;":[247],"may":[250],"relevant":[252],"described":[256],"beneficial":[257],"antiatherosclerotic":[258],"vascular":[264],"level.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073070157","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
